NFKB1 and rheumatoid arthritis: In vitro analyses demonstrated that MASM could suppress the expression of inflammatory mediators by inhibiting MAPK and NF-κB pathways and inducing apoptosis of RA-FLS via the mitochondrial and Akt signaling pathways in human RA-FLS.